ScholarWorks@Korea University College of Medicine: Seo, Hong Seog

Detailed Information

Seo, Hong Seog (서홍석)

Guro Hospital (Department of Cardiology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Acute myocardial infarction:14||coronary artery disease:12||hypertension:10||Coronary artery spasm:9||atrial fibrillation:8||Coronary artery disease:8||Hypertension:8||Acetylcholine:8||Percutaneous coronary intervention:7||Atrial fibrillation:7||acetylcholine:7||percutaneous coronary intervention:7||coronary artery spasm:7||Drugeluting stent:7||drugeluting stent:6||acute myocardial infarction:6||Clinical outcomes:5||Myocardial infarction:5||pulse wave velocity:5||inflammation:5||blood pressure:5||Inflammation:5||amlodipine:4||computed tomography:4||Rosuvastatin:4||Atherosclerosis:4||lipoprotein(a):4||Diabetes mellitus:4||myocardial infarction:4||atherosclerosis:4||Metabolic syndrome:4||Blood pressure:4||dyslipidemia:4||obesity:4||catheter ablation:4||cardiovascular disease:3||AMI:3||arterial stiffness:3||DES:3||positronemission tomography:3||angina:3||Acetylcholine provocation test:3||left atrium:3||diabetes mellitus:3||Echocardiography:3||Creactive protein:3||chronic total occlusion:3||Uric acid:3||endothelial dysfunction:3||Valsartan:3||Sirolimuseluting stents:3||Hypertrophy:3||combination:3||adiponectin:3||exercise:3||left ventricular hypertrophy:3||Prevalence:3||outcomes:3||coronary angiography:2||Antiplatelet therapy:2||coronary heart disease:2||Primary clinics:2||Zotarolimus:2||Chlamydia pneumoniae:2||Insulin resistance:2||critical limb ischemia:2||positron emission tomography:2||Paclitaxeleluting stents:2||Myocardial bridge:2||primary stenting:2||psoas muscle:2||pulse pressure:2||Rwave amplitude:2||Endovascular therapy:2||Calcium channel blocker:2||randomized:2||Contractility:2||air pollution:2||restenosis:2||Coronary vessels:2||LCMS:2||risk factors:2||sarcopenia:2||Resistant hypertension:2||Exercise electrocardiogram:2||Revascularization:2||Obesity:2||angiotensin receptor blocker:2||fimasartan:2||Risk factors:2||Controlled clinical trials:2||aortic stiffness:2||STsegment depression:2||statin:2||Left atrium:2||heart failure:2||Fimasartan:2||stents:2||Biomarker:2||Chronic total occlusion:2||Cardiovascular disease:2||thrombosis:2||Angiotensin converting enzyme inhibitor:2||Computed tomography:2||uric acid:2||Statins:2||left ventricular:2||calcium channel blocker:2||Percutaneous transluminal angioplasty:2||cardiorespiratory fitness:2||lowdensity lipoprotein cholesterol:2||Drug eluting stents:2||medical therapy:2||Drug therapy:2||carvedilol:2||급성심근경색증:2||Test accuracy:2||Catheter ablation:2||Aneurysm:2||clinical outcomes:2||Hyperuricemia:2||심장세동:2||Preeclampsia:2||Vasospastic angina:2||좌심실 비대환자:2||Cryptogenic stroke:1||DOCAsalt hypertension.:1||DOCAsalt rat:1||Deep vein thrombosis of left thigh:1||Delayed severe multivessel spasm:1||Depression:1||Diabetes:1||Diltiazem:1||Dipyridamole:1||Dipyridamole echocardiography:1||Dobutamine echocardiography:1||Drug eluting stent:1||Drugeluting stents:1||Effect of Central Losartan on DOCASalt Hypertension Rats:1||Effects of High Dose Aspirin on Inflammatory Markers and Lipoprotein(a) in Atherosclerotic Vascular Disease:1||Eicosanoids:1||Electric countershock:1||Electrocardiogram:1||Endovascular management:1||Epicardial adipose tissue:1||Epitestosterone:1||Essential hypertension:1||Estrogens:1||Everolimuseluting stents:1||Exercise test:1||F18fluorodeoxyglucose positron emission tomography:1||Fistula:1||Function:1||Glucose Intolerance:1||Graft stent:1||HMGCoA:1||Haematopoietic activity:1||Hair:1||Heart block:1||Heart failure:1||Heart rate variability:1||Hemoglobin A1c:1||Hepatic lipid:1||High cholesterol diet:1||High risk group:1||Highcholesterol diet:1||Homeostasis:1||Hypercholesterolemia:1||Hypertension.:1||Hypertension；Cardiac function tests.:1||Iliac vein compression:1||Immuonglobuli:1||Insulin Resistance:1||Interleukin6:1||Intravascular ultrasound:1||Irbesartan:1||Korean Acute Heart Failure Registry:1||Kynurenine pathway:1||L1 SMI:1||LVH:1||Lacidipine:1||Large coronary artery:1||Left atrial function:1||Left main coronary artery:1||Linear ablation:1||Lipoprotein ( a ):1||Lipoprotein(a):1||Lipoprotein(a) Level in Atherosclerotic Vascular Disease:1||Lipoprotein(e):1||Lipoproteins:1||Liquid chromatographymass spectrometry:1||Liver S9 fraction:1||Longterm clinical outcome:1||Losartan:1||LowMolecularWeightHeparin:1||MACE:1||MDCT:1||Macrophages:1||Major adverse cardiac event:1||Major adverse cardiac events:1||Major clinical outcomes:1||Mass spectrometry:1||Maythurner syndrome:1||Mean platelet volume:1||Medial necrosis:1||Metabolic signatures:1||Metal jacket:1||Midodrine:1||MiniMental State Examination:1||Mitral valve insufficiency:1||Multiplate analyzer:1||Multivessel disease:1||Myocardial contrast echocardiography:1||Myocardial injury:1||Myocardial perfusion.:1||Neuropeptide Y:1||Neutrophil/lymphocyte ratio:1||Newonset diabetes mellitus:1||Noncardiac surgery:1||Nonalcoholic fatty liver disease:1||Osteoarthritis:1||Ouabain:1||Ouabain；DOCAsalt rat；Hypertension.:1||Outcomes:1||Ovariectomy.:1||Pselectin.:1||PFA100:1||PFA200 analyzer:1||PPAR beta/delta:1||PPAR delta:1||PR segment slope:1||PTA:1||PWW:1||Papillary muscles:1||Peripheral artery disease:1||Peripheral vascular disease:1||Plasma:1||Platelet:1||Platelet activation:1||Platelet function:1||Platelet function analyzer200:1||Plateletworks:1||Polymer:1||Polymorphism:1||Positronemission tomography:1||Posterior wall:1||Prepregnancy:1||Primary angioplasty:1||Prognosis:1||Progranulin:1||Proteomic biomarker:1||Psychiatric status rating scales:1||Pulse wave velocity:1||QRS duration:1||Rabbit serum:1||Receptor:1||Receptors:1||Relationship between InStent Restenosis and Persistent Inflammation in Patients with Acute Coronary Syndrome:1||Relationship between Twave normalization on exercise and myocardial functional recovery in patients with acute myocardial infarction:1||Reninangiotensin system inhibitors:1||Reperfusion:1||Reperfusion arrhythmia:1||Resolution:1||Risk factor:1||SCAD:1||SES:1||STsegment myocardial infarction:1||SWS study:1||Sarcopenia:1||Scrup typhus:1||Sex:1||Single coronary artery:1||Sleep deprivation:1||Sleep disorders:1||Sleep quality:1||Smoking:1||Snoring:1||Spasm:1||Stable angina pectoris:1||Stenosis:1||StentBoost:1||Stents:1||Subsequent pregnancy:1||Substance P:1||Tachycardia, atrioventricular nodal reentry:1||Taxus:1||Telmisartan:1||Tetralogy of Fallot:1||Thrombogenecity:1||Topdown lipidomics:1||Urinary tryptophan metabolites:1||Variant angina:1||Vascular endothelium:1||Vascular fistula:1||Vasomotion type:1||Veins.:1||Visceral fat:1||Vit A:1||ZES:1||Zotarolimuseluting stents:1||aPWV:1||acute coronary syndrome:1||adipocytes:1||adipokines:1||adjunctive balloon:1||adrenal steroid:1||adrenergic:1||age:1||aging:1||air pollutant:1||amputation:1||anaemia:1||angiography:1||angiotensin:1||angiotensin II type 1 receptor blocker:1||angiotensin II type 1 receptor blockers:1||angiotensin converting enzyme inhibitor:1||antihypertensive:1||antithrombotic therapy:1||aorta:1||apo Eknockout mouse:1||arteriosclerosis/blood:1||atherosclerotic cardiovascular disease:1||atorvastatin:1||atrial function:1||augmentation index:1||baPWV:1||beta:1||betacarotene:1||bilateral coronary artery fistula:1||biological markers/blood:1||bisoprolol:1||blood glucose:1||blood pressure control:1||blood sugar control:1||body composition:1||body mass index:1||bone marrow:1||cardiac rehabilitation:1||cardiogenic shock:1||cardiomyopathies:1||cardiovascular events:1||cardiovascular outcome:1||cardiovascular risk factor:1||celecoxib:1||central blood pressure:1||central hemodynamics:1||cerebral infarction:1||cholesterol, LDL/analysis/blood/classification/drug effects:1||cilostazol:1||circulation, coronary:1||clinical followup:1||collateral circulation:1||communication between two fistulas:1||constrictive pericarditis:1||controlledrelease formulation:1||coronary:1||coronary artery atherosclerosis:1||coronary artery disease/prevention & control/therapy:1||coronary microvascular function:1||coronary pseudoaneurysm:1||coronary spasm:1||coronary vasodilatory reserve:1||coronary vasospasm:1||cortisol metabolism:1||covered stent:1||cytokines:1||dense lowdensity lipoprotein:1||diabetic:1||diastolic function:1||diltiazem:1||direct intraarterial measurement:1||disease progression:1||dissection:1||drug eluting stent:1||dysglycemia:1||echocardiography:1||electrocardiography:1||endocardium:1||endothelial function:1||epicardial adipose tissue:1||epicardial fat:1||ethnic groups:1||exercise capacity:1||exfoliative dermatitis:1||extracellular fluid:1||fibroelastosis:1||fixeddose combination therapy:1||folate:1||followup:1||global health:1||glucose metabolism:1||hand grip strength:1||handgrip:1||health status disparities:1||healthy volunteers:1||highsensitivity Creactive protein:1||homocysteine:1||hybrid solidphase extractionprecipitation:1||hydroxycholesterol:1||hypercholesterolemia:1||hyperlipidemia:1||hyperlipidemias/prevention & control:1||hyperuricaemia:1||index of microvascular resistance:1||inflammatory:1||insulin resistance:1||intracoronary acetylcholine provocation test:1||large artery stiffness:1||left:1||left atrial function:1||left main ostium:1||left ventricular；Electrocardiogram；Left ventricular mass；Echocardiogram.:1||lipid profile:1||lipid's:1||lipids:1||lipoproteins, LDL/blood/chemistry:1||losartan:1||major adverse cardiac events:1||mannose receptor:1||meloxicam:1||metabolic syndrome:1||miRNA:1||middle aged women:1||minimally invasive direct coronary artery bypass:1||multidetector CT:1||multidetector computed tomography:1||multivessel:1||multivessel coronary artery spasm:1||multivessel disease:1||myocardial contrast echocardiography:1||myogenesis:1||nLCESIMS/MS:1||nUPLCESIMS/MS:1||newonset diabetes mellitus:1||nitrate:1||noncontact mapping:1||nonionic contrast medium (iodixanol):1||nonselective ssblockers:1||nonsteroidal antiinflammatory drugs:1||odds ratio:1||olmesartan medoxomil:1||outcome:1||oxidized low density lipoprotein:1||particle size:1||particular matter:1||percutaneous coronary intervention/adverse effects/mortality:1||pericardial calcification:1||peripartum period:1||peripheral arterial disease:1||peripheral transluminal angioplasty:1||phoshorylcholine:1||pitavastatin:1||plaque:1||platelets:1||polytetrafluoroethylene:1||prediabetes:1||preeclampsia:1||pregnancy:1||pulse wave analysis:1||pyrazolopyridinebased inhibitor:1||qRTPCR:1||quality of life:1||radial artery:1||recanalization:1||recovery of function:1||remodeling:1||reninangiotensin system:1||resampling mediation analysis:1||retinolbinding protein 4:1||retrospective studies:1||revascularization:1||rheumatoid arthritis:1||rosuvastatin:1||safety:1||selective ss 1blockers:1||sex differences:1||simvastatin:1||simvastatin administration and dosage:1||sirolimuseluting stent:1||skeletal muscle:1||skeletal muscle index:1||sleep:1||sleep deprivation:1||small:1||smartphone app:1||smoking:1||social class:1||socioeconomic factors:1||spleen:1||statin responsiveness:1||statin therapy:1||statins:1||stent fracture:1||stroke:1||subacute stent thrombosis:1||superior mesenteric artery aneurysms:1||synchrotron:1||threedimensional multidetector CT:1||thrombolysis in myocardial infarction flow:1||thrombus:1||tissue Doppler:1||trauma:1||treatment outcome:1||type 1:1||type 2 diabetes:1||ultrasonography, Doppler:1||unmonochromatized:1||validation studies:1||variant angina:1||vascular inflammation:1||vasospasm:1||ventricular function:1||visceral artery aneurysms:1||visceral fat:1||visfatin:1||weighting factor:1||zotarolimus:1||；Pulse wave velocity ；Coronary artery atherosclerosis.:1||고혈압·:1||고혈압；심기능검사.:1||고혈압환자에서 Irbesartan 투여가 대동맥 경직도(aortic stiffness)에 미치는 영향:1||관동맥:1||관동맥내 Stent 삽입술시:1||관동맥혈류:1||관상동맥 기형.:1||급성 심근경색환자에서 재관류 후 운동부하 심전도에서 T파의 정상화 소견과 심근기능 회복과의 관계:1||난소 제거된 백서에서 부갑성선 호르몬이:1||대동맥 경직도；맥파 전파속도；관상동맥 동맥경화.:1||동맥경화증；Bcl2 유전자.:1||동정맥기형:1||동정맥루:1||만성:1||메이써너 증후군에 병발된 좌측 총장골정맥 혈전증 1:1||미세혈관기절:1||발작성 심방세동:1||복부비만:1||본태성 고혈압:1||스텐트 혈전；약물 방출 스텐트.:1||심근경색:1||심근기절:1||심방세동:1||심방조동:1||운동:1||이형협심증:1||장기간:1||젊은 연령의 심근경색증 환자에서 Homocysteine의 영향:1||좌심실비대:1||좌심실비대；심전도；좌심실질량；심초음파.:1||좌심실비대에 미치는 영향:1||좌전하행지 관상동맥에서 좌심실로 유출되는 관동정맥루 1예:1||좌측 관상동맥 입구의 완전 협착을 동반한 모야모야 병 1예:1||중년기 여성:1||지질대사의 이해:1||캄실산 암로디핀:1||토끼 장골동맥에 유도철선 삽입 후 발현된 혈관재구도의 양상:1||한국인의 관동맥질환에 띠른 혈중 지질 및 위험인자의 비교연구:1||항고혈압제；칼슘 통로 차단제；혈압.:1||허혈성 심질환에서 관동맥 조영술상의:1||허혈후 심근기절:1||혈류예비능의 변화:1||혈압:1||혈압；맥압；좌심실비대；관동맥질환.:1||혈역학적 반응의 비교연구:1||혈청지질. 혈당:1||(V)over doto(2max):1||흰쥐에서 허혈조건 부여가 허혈 후:1||120170:1||1433 proteinzeta:1||17:1||18FFDGPET/CT:1||20lyase:1||24hour Holter study:1||6minute walk test:1||7 betahydroxycholesterol:1||ADP:1||ALKL1196M mutant:1||Abdominal obesity:1||Ablation time:1||Acetylcholine dose:1||Achinduced coronary vasospasm:1||Ach: acetylcholine:1||Acute Myocardial Infarction:1||Acute coronary syndrome:1||Acute heart failure:1||Acute myocardial infarction (AMI):1||Adenosine:1||Adipokines:1||Adiponectin:1||Adrenergic alpha1 receptor:1||Adventitial inflammation:1||Aerobic glycolysis:1||Alcohol:1||Alzheimer's disease:1||Amiodarone에 의해 각막색소 침착증 1예:1||Amlodipine:1||Amplification efficiency:1||Amygdalar activity:1||Anaplastic lymphoma kinase:1||Angina:1||Angina pectoris:1||Angioplasty:1||Angiotensin:1||Angiotensin II:1||Angiotensin II receptor blocker:1||Angiotensin II type 1 receptor blocker:1||Anomalous origin of left coronary artery from artery；Coronary vessel anomalies；Collateral circulation.:1||Antihypertensive agents ；Calcium chanel blockers ；Blood pressure.:1||Antilipemic agents/therapeutic use:1||Anysis200 analyzer:1||Aortic calcification:1||Aortic stiffness:1||ApoE Knockout Mouse:1||Apolipoprotein E:1||Apolipoprotien(a):1||Arachidonic acid:1||Arterial inflammation:1||Arterial stiffness:1||Arteriovenous fistula:1||Aspirin:1||Assessment fo coronary flow reserve with transthoracic Doppler echocardiography:1||Aster glehni:1||Atherogenesis:1||Atherosclerosis；Bcl2 genes:1||Atorvastatin:1||Atrial mass:1||Atrial septal aneurysm:1||Awareness:1||Btype natriuretic peptide:1||BMS:1||Baremetal stent:1||Betablocker:1||BioLinx:1||Blood glucose:1||Blood pressure；Pulse pressure；Left ventricular hypertrophy；Coronary artery disease.:1||Body size phenotype:1||Brain:1||C1q/tumor necrosis factorrelated protein3:1||CAS:1||CV events:1||Cardiac CT:1||Cardiac autonomic dysfunction:1||Cardiac hypertrophy induced cell:1||Cardiopulmonary coupling analysis:1||Cardiovascular diseases:1||Cardiovascular event:1||Cardiovascular outcome:1||Carrageenan:1||Cataract:1||Celiprolol.:1||Cesarean section:1||Changes of Mitral and PulmonicVenous Flow Velocity Dyring Dipyridamole Induced Myocardial Ischemia:1||Cholesterol:1||Cholesterol absorption:1||Cholesterol biosynthesis:1||Cholesterol signatures:1||Cigarette smoking:1||Cilostazol:1||Circardian variation.:1||Circumflex coronary artery:1||Clinical followup:1||Clinical outcome:1||Clodronate:1||Clompramine에 의해 유발된 만성 확장성 심근증:1||Collagen:1||Compensatory remodeling:1||Complex fractionated atrial electrograms:1||Compliance；Coronary atherosclerosis；Oscillometry.:1||Congenital:1||Contrastenhanced magnetic imaging(ceMRI):1||Contrastenhanced magnetic resonance imaging (ceMRI):1||Coronary angiogram:1||Coronary angiography:1||Coronary anomaly:1||Coronary arteriovenous malformation:1||Coronary artery:1||Coronary artery stenosis:1||Coronary artery vasospasm:1||Coronary calcification:1||Coronary circulation:1||Coronary disease:1||Coronary flow reserve:1||Coronary occlusion:1||Coronary occlusion/therapy:1||Coronary restenosis:1||Coronary rupture:1||Coronary stenosis:1||Coronary stent:1||Coronary thrombosis ；Stents.:1||Coronary vessel anomalies.:1||Critical limb ischemia:1||

STATISTICS: Total View :12,989,277; Today View :4,027

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE